Back to: products

Europe Bioelectric Medicine Market 2020-2030 by Product Type (Implantable, Non-invasive), End User, and Country: Trend Forecast and Growth Opportunity

PrintEmail
Dec 2021 - 141 Pages - From $2,780
(Excel Data Sheet: $1,800)
Description

The report cover may be different from the image shown.

Product and Price

By clicking the Add to Shopping Cart button, you certify to agree with our Terms of Service.

Bioelectric medicines, also known as electroceuticals, are medical devices that are used to restore health in patients. Bioelectric medicines function through neurostimulation and modulation of the nervous systems through electrical impulses. Europe bioelectric medicine market was valued at $5,859.6 million in 2020 and will grow by 6.4% annually over 2020-2030 owing to the growing geriatric population and rising acceptance of bioelectric medicines.
Highlighted with 70 tables and 43 figures, this 141-page report “Europe Bioelectric Medicine Market 2020-2030 by Product Type (Implantable, Non-invasive), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe bioelectric medicine market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate/forecast from 2020 till 2030 with 2019 as the base year.
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe bioelectric medicine market in every aspect of the classification from perspectives of Product Type, End User, and Country.

Based on Product Type, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Implantable Bioelectric Medicine
o Cardiac Pacemaker
o Implantable Cardioverter Defibrillators (ICD)
o Spinal Cord Stimulators (split into Chronic Pain, Failed Back Syndrome (FBSS), Ischemia by application)
o Cochlear Implants
o Deep Brain Stimulators (split into Parkinson’s Disease, Tremor, Depression, Other Deep Brain Stimulation Applications by application)
o Vagus Nerve Stimulators
o Sacral Nerve Stimulators (split into Urinary Incontinence and Fecal Incontinence by application)
o Retinal Implants
o Other Implantable Bioelectric Medicines
• Non-invasive Bioelectric Medicine
o Transcutaneous Electrical Nerve Stimulators
o Transcranial Magnetic Stimulation (TMS)
o Pulsed Electromagnetic Field Therapy
o Other Non-invasive Bioelectric Medicines

Based on End User, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Hospitals and Clinics
• Research Institutes
• Individual Users

Geographically, the following national/local markets are fully investigated:
• Germany
• UK
• France
• Spain
• Italy
• Russia
• Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of the regional market by country and split of key national markets by Product Type and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in Europe bioelectric medicine market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
Abbott Laboratories
BIOTRONIK SE & Co. KG
Boston Scientific Corporation
Cochlear Limited
electroCore, Inc.
Inspire Medical Systems, Inc.
LivaNova PLC
Medtronic PLC
NeuroMetrix, Inc
Nevro Corp.
Nuvectra Corporation
OMRON CORPORATION
Pixium Vision
Second Sight Medical Products Inc
SetPoint Medical
Sonova Holding AG
St. Jude Medical, Inc.
Stimwave LLC
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 18
2.1 Market Size and Forecast 18
2.1.1 Impact of COVID-19 on World Economy 19
2.1.2 Impact of COVID-19 on the Market 21
2.2 Major Growth Drivers 23
2.3 Market Restraints and Challenges 29
2.4 Emerging Opportunities and Market Trends 32
2.5 Porter’s Fiver Forces Analysis 36
3 Segmentation of Europe Market by Product Type 40
3.1 Market Overview by Product Type 40
3.2 Implantable Bioelectric Medicine 42
3.2.1 Cardiac Pacemaker 44
3.2.2 Implantable Cardioverter Defibrillators (ICD) 45
3.2.3 Spinal Cord Stimulators 46
3.2.4 Cochlear Implants 47
3.2.5 Deep Brain Stimulators 48
3.2.6 Vagus Nerve Stimulators 49
3.2.7 Sacral Nerve Stimulators 50
3.2.8 Retinal Implants 51
3.2.9 Other Implantable Bioelectric Medicines 52
3.3 Non-invasive Bioelectric Medicine 53
3.3.1 Transcutaneous Electrical Nerve Stimulators 55
3.3.2 Transcranial Magnetic Stimulation (TMS) 56
3.3.3 Pulsed Electromagnetic Field Therapy 57
3.3.4 Other Non-invasive Bioelectric Medicines 58
4 Segmentation of Europe Market by End User 59
4.1 Market Overview by End User 59
4.2 Hospitals and Clinics 61
4.3 Research Institutes 62
4.4 Individual Users 63
5 European Market 2020-2030 by Country 64
5.1 Overview of European Market 64
5.2 Germany 67
5.3 UK 69
5.4 France 71
5.5 Spain 73
5.6 Italy 75
5.7 Russia 77
5.8 Rest of European Market 79
6 Competitive Landscape 81
6.1 Overview of Key Vendors 81
6.2 New Product Launch, Partnership, Investment, and M&A 87
6.3 Company Profiles 88
Abbott Laboratories 88
BIOTRONIK SE & Co. KG 91
Boston Scientific Corporation 95
Cochlear Limited 99
electroCore, Inc. 102
Inspire Medical Systems, Inc. 104
LivaNova PLC 106
Medtronic PLC 108
NeuroMetrix, Inc 112
Nevro Corp. 114
Nuvectra Corporation 116
OMRON CORPORATION 118
Pixium Vision 121
Second Sight Medical Products Inc 124
SetPoint Medical 127
Sonova Holding AG 129
St. Jude Medical, Inc. 131
Stimwave LLC 133
7 Investing in Europe Market: Risk Assessment and Management 135
7.1 Risk Evaluation of Europe Market 135
7.2 Critical Success Factors (CSFs) 138
Related Reports and Products 141

List of Tables:

Table 1. Snapshot of Europe Bioelectric Medicine Market in Balanced Perspective, 2020-2030 17
Table 2. Growth Rate of World GDP, 2020-2022 20
Table 3. Projection of Europe Disease Incidences Treated by Bioelectric Medicine, 2019-2030, million 26
Table 4. World Health Spending by Region, $ bn, 2013-2020 28
Table 5. Selected Examples of Product Recalls 31
Table 6. Main Product Trends and Market Opportunities in Europe Bioelectric Medicine Market 32
Table 7. Europe Bioelectric Medicine Market by Product Type, 2019-2030, $ mn 40
Table 8. Europe Implantable Bioelectric Medicine Market by Product Type, 2019-2030, $ mn 43
Table 9. Europe Bioelectric Medicine Market: Spinal Cord Stimulators by Application, 2019-2030, $ mn 46
Table 10. Europe Bioelectric Medicine Market: Deep Brain Stimulators by Application, 2019-2030, $ mn 48
Table 11. Europe Bioelectric Medicine Market: Sacral Nerve Stimulators by Application, 2019-2030, $ mn 50
Table 12. Europe Non-invasive Bioelectric Medicine Market by Product Type, 2019-2030, $ mn 54
Table 13. Europe Bioelectric Medicine Market by End User, 2019-2030, $ mn 59
Table 14. Europe Bioelectric Medicine Market by Country, 2019-2030, $ mn 66
Table 15. Germany Bioelectric Medicine Market by Product Type, 2019-2030, $ mn 68
Table 16. Germany Bioelectric Medicine Market by End User, 2019-2030, $ mn 68
Table 17. UK Bioelectric Medicine Market by Product Type, 2019-2030, $ mn 70
Table 18. UK Bioelectric Medicine Market by End User, 2019-2030, $ mn 70
Table 19. France Bioelectric Medicine Market by Product Type, 2019-2030, $ mn 72
Table 20. France Bioelectric Medicine Market by End User, 2019-2030, $ mn 72
Table 21. Spain Bioelectric Medicine Market by Product Type, 2019-2030, $ mn 74
Table 22. Spain Bioelectric Medicine Market by End User, 2019-2030, $ mn 74
Table 23. Italy Bioelectric Medicine Market by Product Type, 2019-2030, $ mn 76
Table 24. Italy Bioelectric Medicine Market by End User, 2019-2030, $ mn 76
Table 25. Russia Bioelectric Medicine Market by Product Type, 2019-2030, $ mn 78
Table 26. Russia Bioelectric Medicine Market by End User, 2019-2030, $ mn 78
Table 27. Bioelectric Medicine Market in Rest of Europe by Country, 2019-2030, $ mn 80
Table 28. Spinal Cord Stimulation Device Market by Key Vendor, 2019, % 83
Table 29. Cochlear Implant Market by Key Vendor, 2019, % 83
Table 30. Pacemaker and ICD Market by Key Vendor, 2019, % 83
Table 31. FDA Approved Products of Key Vendors 84
Table 32. Abbott Laboratories: Company Snapshot 88
Table 33. Abbott Laboratories: Business Segmentation 89
Table 34. Abbott Laboratories: Product Portfolio 89
Table 35. Abbott Laboratories: Revenue, 2018-2020, $ mn 90
Table 36. BIOTRONIK SE & Co. KG: Company Snapshot 91
Table 37. Boston Scientific Corp.: Company Snapshot 95
Table 38. Boston Scientific Corp.: Business Segmentation 95
Table 39. Boston Scientific Corp.: Product Portfolio of Medical Devices 96
Table 40. Cochlear Limited: Company Snapshot 99
Table 41. Cochlear Limited: Operational Overview with Sales Revenue ($ mn) and Sales Volume (units), 2020-2021 99
Table 42. Cochlear Limited: Product Portfolio 100
Table 43. electroCore, Inc.: Company Snapshot 102
Table 44. Inspire Medical Systems, Inc..: Company Snapshot 104
Table 45. LivaNova PLC: Company Snapshot 106
Table 46. LivaNova PLC: Product Portfolio 107
Table 47. Medtronic Inc.: Company Snapshot 108
Table 48. Medtronic Inc.: Net Revenue by Segment, 2018-2020, $ bn 109
Table 49. Medtronic Inc.: Net Revenue by Region, 2017-2019, $ bn 109
Table 50. Medtronic Inc.: Product Portfolio of Medical Devices 109
Table 51. Medtronic Inc.: Product Portfolio of Bioelectric Medicine 110
Table 52. NeuroMetrix, Inc: Company Snapshot 112
Table 53. NeuroMetrix, Inc: Product Portfolio 113
Table 54. Nevro Corp.: Company Snapshot 114
Table 55. Nevro Corp.: Product Portfolio 115
Table 56. Nuvectra Corporation: Company Snapshot 116
Table 57. Omron Corporation: Company Snapshot 118
Table 58. Omron Corporation: Business Segmentation 119
Table 59. Pixium Vision: Company Snapshot 121
Table 60. Pixium Vision: Product Portfolio 122
Table 61. Second Sight Medical Products Inc: Company Snapshot 124
Table 62. Second Sight Medical Products Inc: Product Portfolio 125
Table 63. SetPoint Medical: Company Snapshot 127
Table 64. Sonova Holding AG: Company Snapshot 129
Table 65. Sonova Holding AG: Main Brands and Products 130
Table 66. St. Jude Medical, Inc.: Company Snapshot 131
Table 67. Stimwave LLC: Company Snapshot 133
Table 68. Stimwave LLC: Product Portfolio 134
Table 69. Risk Evaluation for Investing in Europe Market, 2020-2030 136
Table 70. Critical Success Factors and Key Takeaways 139

 

 

List of Figures:

Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2020-2030 16
Figure 4. Europe Bioelectric Medicine Market, 2019-2030, $ mn 18
Figure 5. Impact of COVID-19 on Business 21
Figure 6. Primary Drivers and Impact Factors of Europe Bioelectric Medicine Market 23
Figure 7. Worldwide Geriatric Population (60 years and above) by Region, 2015 & 2030, million 27
Figure 8. World Population 65 and over, % of Total Population, 1950-2060 27
Figure 9. Primary Restraints and Impact Factors of Europe Bioelectric Medicine Market 29
Figure 10. Investment Opportunity Analysis 33
Figure 11. Porter’s Fiver Forces Analysis of Europe Bioelectric Medicine Market 36
Figure 12. Breakdown of Europe Bioelectric Medicine Market by Product Type, 2020-2030, % of Sales Revenue 40
Figure 13. Europe Addressable Market Cap in 2021-2030 by Product Type, Value ($ mn) and Share (%) 41
Figure 14. Europe Bioelectric Medicine Market: Implantable Bioelectric Medicine, 2019-2030, $ mn 42
Figure 15. Europe Bioelectric Medicine Market: Cardiac Pacemaker, 2019-2030, $ mn 44
Figure 16. Europe Bioelectric Medicine Market: Implantable Cardioverter Defibrillators (ICD), 2019-2030, $ mn 45
Figure 17. Europe Bioelectric Medicine Market: Spinal Cord Stimulators, 2019-2030, $ mn 46
Figure 18. Europe Bioelectric Medicine Market: Cochlear Implants, 2019-2030, $ mn 47
Figure 19. Europe Bioelectric Medicine Market: Deep Brain Stimulators, 2019-2030, $ mn 48
Figure 20. Europe Bioelectric Medicine Market: Vagus Nerve Stimulators, 2019-2030, $ mn 49
Figure 21. Europe Bioelectric Medicine Market: Sacral Nerve Stimulators, 2019-2030, $ mn 50
Figure 22. Europe Bioelectric Medicine Market: Retinal Implants, 2019-2030, $ mn 51
Figure 23. Europe Bioelectric Medicine Market: Other Implantable Bioelectric Medicines, 2019-2030, $ mn 52
Figure 24. Europe Bioelectric Medicine Market: Non-invasive Bioelectric Medicine, 2019-2030, $ mn 53
Figure 25. Europe Bioelectric Medicine Market: Transcutaneous Electrical Nerve Stimulators, 2019-2030, $ mn 55
Figure 26. Europe Bioelectric Medicine Market: Transcranial Magnetic Stimulation (TMS), 2019-2030, $ mn 56
Figure 27. Europe Bioelectric Medicine Market: Pulsed Electromagnetic Field Therapy, 2019-2030, $ mn 57
Figure 28. Europe Bioelectric Medicine Market: Other Non-invasive Bioelectric Medicines, 2019-2030, $ mn 58
Figure 29. Breakdown of Europe Bioelectric Medicine Market by End User, 2020-2030, % of Sales Revenue 59
Figure 30. Europe Addressable Market Cap in 2021-2030 by End User, Value ($ mn) and Share (%) 60
Figure 31. Europe Bioelectric Medicine Market: Hospitals and Clinics, 2019-2030, $ mn 61
Figure 32. Europe Bioelectric Medicine Market: Research Institutes, 2019-2030, $ mn 62
Figure 33. Europe Bioelectric Medicine Market: Individual Users, 2019-2030, $ mn 63
Figure 34. Breakdown of European Bioelectric Medicine Market by Country, 2019 and 2030, % of Revenue 65
Figure 35. Contribution to Europe 2021-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 66
Figure 36. Bioelectric Medicine Market in Germany, 2019-2030, $ mn 67
Figure 37. Bioelectric Medicine Market in UK, 2019-2030, $ mn 69
Figure 38. Bioelectric Medicine Market in France, 2019-2030, $ mn 71
Figure 39. Bioelectric Medicine Market in Spain, 2019-2030, $ mn 73
Figure 40. Bioelectric Medicine Market in Italy, 2019-2030, $ mn 75
Figure 41. Bioelectric Medicine Market in Russia, 2019-2030, $ mn 77
Figure 42. Bioelectric Medicine Market in Rest of Europe, 2019-2030, $ mn 79
Figure 43. Growth Stage of Europe Bioelectric Medicine Industry over the Forecast Period 81

Reviews

There are yet no reviews for this product.